摘要 |
The present invention provides novel compounds of Formula (I), its prodrug forms, or pharmaceutically acceptable salts thereof. The compounds of this invention are inhibitors of serine proteases, Urokinase (uPA), Factor Xa (FXa), and/or Factor VIIa (FVIIa), and have utility as anti cancer agents and/or as anticoagulants for the treatment or prevention of thromboembolic disorders in mammals. The present invention also provides a process for the selective acylation of an amino group.
|
申请人 |
AXYS PHARMACEUTICALS, INC.;ALLEN, DARIN, ARTHUR;MCGEE, DANNY, PETER, CLAUDE;SPENCER, JEFFREY, R. |
发明人 |
ALLEN, DARIN, ARTHUR;MCGEE, DANNY, PETER, CLAUDE;SPENCER, JEFFREY, R. |